Advertisements

Peter Reynolds

The life and times of Peter Reynolds

Posts Tagged ‘CBD

The Facts About CBD In The UK. April 2018.

leave a comment »

 

This article is an update to ‘The Facts About CBD In The UK. December 2016.

The past three years have seen a true phenomenon develop around the cannabis law reform movement which has quickly crossed into mainstream society, commerce and general awareness.  It’s the explosion of the CBD market, a trade that has grown from zero to £50 million per annum in the UK in this very short period.

There has been a great deal of nonsense published about the market, the products and their legality both under drugs laws, food and medicines regulation. The facts that are set out in this article are established from close involvement with the developing market on a daily basis as well as consultation with a number of lawyers of all types and levels of experience as well as direct contact with the Home Office, the Medicines and Healthcare products Regulatory Agency (MHRA), the Food Standards Agency (FSA) and other authorities.

The market has been driven initially because of growing interest in the medical benefits of cannabis and the recognition that, within certain constraints, products derived from low-THC cannabis, legally grown under licence as industrial hemp, are a legal alternative.  An important factor has been that CBD is most often consumed by placing a few drops of oil under the tongue. This has avoided the stigma of smoking a joint and is more in line with the way people perceive a medicine or health food.

The CBD market has also exposed the contradictions, inconsistencies and errors in the Misuse of Drugs legislation and particularly in the confused and inconsistent way in which the Home Office attempts to administer it. For instance, currently there are CBD products produced legally in other EU countries and the USA which can legally be sold in the UK but which the Home Office will not permit UK companies to produce.

Ironically, the most significant development has been that responsible CBD suppliers have moved away from claiming the sort of medical benefits that are, in fact, the reason for the market’s existence.  Although everyone knows this is why people are buying CBD, if you’re in the business of supplying the products you can’t say a thing, not even indirectly, about the medical benefits it offers.

18 months ago, all the leading and responsible suppliers of CBD products in the UK joined together to create their own trade association.  The Cannabis Trades Association UK (CTA UK) now represents 80% by turnover of all the CBD suppliers in the UK. It is governed by its members who have established a set of standards on products, labelling and marketing which all abide by.  These standards are designed to protect and inform consumers and to ensure that all CTA UK members are compliant with the law.

The formation of CTA UK was prompted by the MHRA issuing warnings to some suppliers about making medical claims for their products. To remain within the law, CBD products must be sold as food supplements and the most that can be said about them is that they help to improve and maintain health and wellbeing.  Before any product can be marketed with medicinal claims it must have a marketing authorisation from the MHRA. Food supplements must also comply with certain laws and regulations administered by the FSA.

CTA UK is now engaged in a continuous dialogue with both the MHRA and FSA.  Regular meetings are held to consider new suppliers and products entering the market to ensure they comply with the law, regulations and CTA UK standards.

When supplied by a CTA UK member, consumers can be certain that the product they are buying is 100% legal and is accurately labelled and described.  CBD is not a ’controlled drug’.  It does not appear in any of the classifications or schedules to the Misuse of Drugs Act 1971.

There is widespread misunderstanding about the 0.2% THC limit in industrial hemp.  This is the limit in the growing plant and is not relevant to CBD products.  Clearly what may be under 0.2% in the growing plant would be far higher in an extract which is, by definition, concentrated. The Misuse of Drugs Regulations 2001 make it clear that any product derived from low-THC cannabis grown legally under licence as industrial hemp is “exempt” provided it contains “not more than one milligram” of THC or CBN. This is the limit that matters. See The Misuse of Drugs Regulations 2001 ‘Interpretation’ 2-(1) (a)(b)(c)

Contrary to suggestions that the market is “in chaos”, “half-legal”, “a bit of a mess” and other spurious claims, in fact, it is a model of self-regulation where the industry itself has put aside its competitive instincts to co-operate for the benefit of consumers and in its own long term self-interest.

No suppliers will be admitted to membership of CTAUK unless they cease making medicinal claims, stop selling illegal products (for instance with high levels of THC, described as ‘indica’ or intended for pets or veterinary purposes).  Indeed, any suppliers that continue such conduct are likely to be subject to enforcement action by the MHRA and Trading Standards.

There are further changes or clarifications in the law relating to some CBD products which have emerged in the last few weeks.  These arise out of regulations from the FSA.  Isolates or pure CBD are now no longer permitted as they have been classified as ‘novel foods’.  This could mean a prison sentence of up to two years for anyone selling them.

It’s a myth, although regularly reported in the press, that there has been any change in the law or that CBD has been made legal or classified as a medicine. CBD products can already be prescribed by doctors without any restriction, just as any other food supplement. When the inevitable cannabis law reform takes place it will still be unlawful to make medicinal claims about any CBD or cannabis product without a marketing authorisation from the MHRA.

Within the next few months, the first CBD medicine will receive a marketing authorisation from the MHRA. Epidiolex, a whole plant extract, refined to deliver 98% CBD, is GW Pharmaceuticals’ second cannabis-derived prescription medicine which is intended for severe forms of paediatric epilepsy. It is not derived from industrial hemp but from high CBD strains of cannabis grown specifically for the purpose. It should be noted that this is to be administered in massive doses of up to 20 mg per day per kg of body weight,  CBD as a food supplement for adults has a maximum recommended dose of 200mg per day.

The CBD food supplement market will continue to grow.  Other medicines may be authorised in the near future, most likely under the MHRA’s Traditional Herbal Registration scheme, which will permit them to be described as medicines for minor ailments not requiring the supervision of a doctor.

Clearly, it remains urgent that our government gets to grips with the reality of the need and benefits of cannabis for medical use in the wider sense. However, even as we begin to make progress the CBD market in its present form will continue to fulfil an important need for many years to come.

 

 

 

 

Advertisements

Talking Cannabis With the MHRA

with 4 comments

MHRA Headquarters

In November 2016 I organised a meeting with the Medicines and Healthcare products Regulatory Agency (MHRA) and a number of key players in the CBD market.  It was in response to the MHRA seeking to clamp down on sales of CBD oil and related products.  That meeting led directly to the formation of the Cannabis Trades Association UK (CTAUK) which now represents more than 80% by turnover of all CBD suppliers in the UK.

Since that first meeting my friend and colleague Mike Harlington has taken on the leadership role at CTAUK and I give him great credit for what has been achieved.  We expect formal recognition by the MHRA is only a few weeks away and that is a tremendous coup.  For the first time ever, in the face of total intransigence by government, we have established to a significant degree a legally regulated cannabis market.  Clearly, it doesn’t yet go anywhere near far enough but this is the most concrete move ever towards long overdue cannabis law reform.

The first 18 months of CTAUK have not been easy.  Other than the MHRA, the other branches of government concerned are the Food Standards Agency (FSA) and the Home Office.  The FSA has also become a close working partner but, unsurprisingly, the Home Office remains difficult and our efforts to engage constructively with it have been characterised by responses that are inconsistent, irrational, contradictory and a realisation that it’s losing its grip on cannabis policy.  It is impossible to deal with.  In fact, I almost sympathise with the unfortunate civil servants charged with administering a policy that is itself irrational and contradictory and driven only by outdated prohibitionist values.  Maladministration of the Misuse of Drugs Act is now a persistent reality and several legal challenges to the Home Office’s conduct are imminent.  Soon the High Court will become involved in UK cannabis policy and then, in theory, facts and evidence should prevail rather than propaganda and government disinformation.

Dr Chris Jones

The CTAUK has been engaged in regular meetings with the MHRA and I was invited along for the most recent occasion.  The CTAUK team was Mike Harlington, Tom Whettem of Canabidol and myself.  The MHRA team was Dr Chris Jones, head of the Borderline Medicines section and Raj Gor. We discussed many administrative matters and gave a great deal of time again to discussing medicinal claims and how members could avoid mistakes.  It seems obvious that no claims of medicinal benefit can be made but there are many instances where it’s not clear cut.  A particular case we looked at was the use of ‘night’ and ‘day’ CBD products.  Eventually it was agreed that this description is acceptable but only just. This is an excellent example of how CTAUK works to represent its members’ interests and with goodwill on both sides how positive agreement can be reached.

On a continuing, day-to-day basis CTAUK and MHRA are in constant touch, ironing out problems, asking for and taking advice from each other.  I am impressed with the way the relationship has evolved and jointly we bring great benefit to the industry and consumers.

Reefer Madness 3.0 Is Here And It’s Being Promoted By Cannabis Law Reformers.

with 6 comments

Reefer Madness started in 1930s America with the propaganda film of the same name.

Reefer Madness 2.0 was promoted by the Daily Mail from 2003 onwards after cannabis was classified downwards to a class C drug.  It was strongly supported by the Labour Party through home secretaries Jacqui Smith, Alan Johnson and prime minister Gordon Brown.

Reefer Madness 3.0 is its latest incarnation but this time it’s promoted by reform groups Transform, which has been around as long as CLEAR and Volteface, which is a new group funded by Paul Birch’s personal fortune.  (Birch was also the founder of the now defunct Cannabis Is Safer Than Alcohol (CISTA) political party.)  Despite the overwhelming body of scientific evidence and the facts of healthcare records which show that cannabis is an insignificant health problem, both Transform and Volteface argue that ‘cannabis is dangerous so it must be regulated’.

Click to download

This is nonsense.  Cannabis is not dangerous, in fact for most people it’s beneficial.  It’s prohibition and enforcement of the law against cannabis that are dangerous.  Prohibition has caused far more harm than cannabis ever has or ever could.  Cannabis needs to be regulated because prohibition is dangerous.

I’m very disappointed by the new, much-hyped Volteface report ‘Street Lottery’. It offers nothing new, either in information or in proposed solutions. It takes us no further on from Transform’s work in 2009 or CLEAR’s proposals from 2011.  What it does is ramp up the unjustified scaremongering and panic about high THC and low CBD levels.  It panders slavishly to the exaggerated studies on psychosis from the Institute of Psychiatry and wildly overstates the health harms that, in fact, only occur in a very small number of people.

That’s not to say that we shouldn’t do all we can to protect those very few people for whom cannabis can be a problem and we should certainly educate about harm reduction.  The most important message is that the most dangerous thing about cannabis is mixing it with tobacco.

It’s worth saying that in my opinion, cannabis is a better product when it has higher levels of CBD than usually found in what’s generally available today.  When I say better, I mean more pleasant for recreational use and more effective for medicinal use and it is the ratio of THC:CBD that is more important than the absolute levels.  10:1 THC:CBD is plenty adequate enough to provide the benefits of CBD, any higher that 3:1 and it begins to wipe out the benefits of THC.  It certainly is true that younger people and novice users are best with higher levels of CBD.

Of course I understand that arguing for regulation as a means of reducing harm should encourage politicians towards reform.  I’m all for that but we don’t have to exaggerate the health harms and overlook the massive social harms in order to do that. However, it’s blindingly obvious that decisions on drugs policy are not made rationally, so what’s the point?  Our politicians have failed to act on cannabis law reform, despite the solution to the harms of the criminal market being obvious for more than 30 years. Ministers are completely disinterested in effective drugs policy. The truth about their attitude is best illustrated by the Psychoactive Substances Act. This disastrous legislation is regarded as a success because it has taken the sale of NPS off the high street and driven it underground. This is all that ministers care about. They have been seen to do something and these drugs are no longer so obviously available. They really don’t give a damn that use has increased, harms have multiplied and deaths are becoming increasingly common.

Where the Volteface report actually takes us backwards is its pandering to renewed reefer madness and vast exaggeration of the harms of cannabis.

Correct, cannabis can be harmful to a tiny minority of consumers. All the speculative studies from Robin Murray and his team at the Institute of Psychiatry, all the scaremongering hyperbole in what is presented as ‘scientific’ evidence, all the esoteric, statistical tricks that create alarming headlines – none of these can change the hard facts of how infinitesimal is the number of people whose health is genuinely impaired by cannabis.

It’s ‘young people’ that all the concern is about but in the last five years there has been an average of just 28 cases per year of cannabis-induced psychosis – a tragedy for the individuals but a problem that is irrelevant in public health terms: https://www.theyworkforyou.com/wrans/?id=2015-03-17.227980.h&s=drug

For the entire population the total number of finished admission episodes (FAE) for ‘mental and behavioural problems due to use of cannabinoids’ in 2015 – 16 was 1606.  A very long way from a problem of huge significance and you don’t be have to be an expert to realise that a very large proportion of those are due to ‘Spice’, suynthtrci cannabinoids which can have severe health effects.

For GP and community health treatment, Public Health England’s own data shows that 89% of under-18s in treatment are coerced into it, only in 11% of cases does the patient themselves or their families believe they need it: See table 2.4.1 http://www.nta.nhs.uk/uploads/young-peoples-statistics-from-the-ndtms-1-april-2015-to-31-march-2016.pdf

I welcome any new entrant to the drugs policy reform movement. We need all the help we can get but all Volteface has done since its inception is repeat the work already done by other groups. Now it is pursuing the same flawed and misguided route as Transform. It’s worth repeating – cannabis doesn’t need to be regulated because it is dangerous, it isn’t, cannabis needs to regulated because prohibition is dangerous.

US Surgeon General Joycelyn Elders

Note that this mythical ‘mental health crisis’ only seems to exist in the UK. It doesn’t exist in the rest of Europe, the USA, Israel or other jurisdictions where cannabis is legally avalable. Note also that former US Surgeon General Joycelyn Elders is published in the November edition of the American Journal of Public Health saying “The unjust prohibition of marijuana has done more damage to public health than has marijuana itself.”

The valuable contribution Volteface has made so far to cannabis law reform is the money it has spent on professional media relations. This has elevated the subject up the news agenda and that is a very good thing indeed. Everyone, cannabis consumers and those who don’t have the slightest interest, will benefit from legalisation. The sooner we get on with it the better.  A legal, regulated market will help protect the few dozen children and few hundred adults who are vulnerable to possible health harms.  Much, much more important it will halt the enormous harm that prohibition causes.

 

Irresponsible, Reckless BBC Broadcasts Dangerous Claim That So-Called ‘Skunk’ is More Harmful Than Heroin.

with 6 comments

Louisa Philips Kulukundis. Psychotherapist at Soul Counselling, counsellor at Steps2Recovery, member of the British Association for Counselling and Psychotherapy.

“I would say give me a room full of heroin addicts than skunk addicts…

I remember saying to my older son I would prefer you to take heroin than to smoke skunk…

There will be generations of kids with severe mental health issues.”

Source: ‘Cannabis: Time for a Change?’ From 28:20

There is huge and justifiable righteous anger about the idiotic words spoken by this woman on the BBC Newsbeat documentary ‘Cannabis: Time for a Change?’

It would be easy to launch into a tirade against Ms Kulukundis but her words and their crass stupidity speak for themselves. I wonder how many kids, listening to her recommendation on the BBC’s ‘yoof’ channel will think ‘Well I’ve smoked weed loads of times with no trouble, now this woman who’s an expert says heroin is safer, maybe I’ll see if I can get hold of some.’

I understand that Ms Kulukundis supports the idea that cannabis with a higher proportion of CBD should be legally available instead of so-called ‘skunk’ which with zero or very little CBD dominates today’s illegal market.  She deserves credit for this and I would be very surprised if she wasn’t already regretting the very serious mistake she has made.

Ms Kulukundis does however subscribe to the falsehood that cannabis is a major cause of mental health problems.  The facts of hospital admissions and GP/community health service treatment prove this is not the case.  While we shouldn’t turn away from protecting those very few people who can be vulnerable, it is about time that the media started reporting accurately instead of the gross distortions and misrepresentation seen recently, particularly from the brazenly dishonest and ‘fake news’ Daily Telegraph.

Far, far more serious and the place where responsibility really lies for this broadcast is with the BBC.  Its negligence in allowing these words to be broadcast is unforgivable and CLEAR is pursuing a complaint.  The BBC’s complaints procedure is of course notorious for its determination to brush aside viewers’ concerns with anodyne responses that mean nothing. Many don’t realise that until you get to stage three you’re not even communicating with the BBC but with Capita to whom it outsources its complaints handling.  We will pursue this complaint until it reaches the BBC Editorial Complaints Unit and if necessary we will appeal it to OFCOM which, with the demise of the BBC Trust, is now the independent regulator.

It is a shame that the BBC has spoiled what is a clear shift in its position on cannabis.  Instead of mindless obedience to the government’s bad science and propaganda it is now recognising that reform is the only rational way forward.  As usual its coverage is dominated by stereotypical caricatures of what it regards as cannabis users.  It still seems incapable of recognising that most of the three million regular cannabis consumers in the UK are not relics of the hippy era but hardworking people with families and ‘ordinary’ lifestyles.  It also allowed its debate programme ‘Newsbeat Debates. Legalising Cannabis’ to be dominated by the ‘Gateway Theory’, an idea comprehensively disproven many times over, which even our prohibitionist government recognises is invalid.  What is the point of debate if it is hijacked by misinformation and not informed by science and evidence?

The BBC should take the initiative in apologising, correcting and broadcasting a full explanatuion of why Ms Kulukundis’ claim is scientifically inaccurate and extremely dangerous. Sadly, it will almost certainly have to be dragged kicking and screaming to provide any meaningful response at all.

 

 

 

Why Is CLEAR Supporting Lord Monson In His Campaign Against So-Called ‘Skunk’?

leave a comment »

Lord Nicholas Monson

Lord Nicholas Monson

CLEAR’s first and overriding objective is to end the prohibition of cannabis.  The tragedies that have struck the Monson family demonstrate all too clearly that prohibition of cannabis is futile.  Not only does it not protect people from harm, it actually maximises the harms and dangers of the cannabis market.

Nicholas Monson’s eldest son, Alexander, was arrested in Kenya in 2012. allegedly for smoking cannabis.  Toxicology reports found no evidence of cannabis in his system. According to both a government and an independent pathologist he died from a fatal blow to the back of his head while in police custody.  Clearly, it was the law against cannabis that led directly to Alexander’s death.

Nicholas Monson with his son Rupert

Just three months ago, Rupert, Nicholas Monson’s younger son, took his own life after a descent into depression and psychosis in which the excessive consumption of so-called ‘skunk’ was clearly a significant factor.  Rupert himself said that he was addicted and there is good evidence to show that cannabis without CBD is more addictive.  It is well established from research as far back as the early 1990s that approx 9% of regular users develop dependence which produces real physical withdrawal symptoms: insomnia, lack of appetite and irritability, sometimes a headache.  For most people these are easily overcome within a week or so but not for everyone.  Most importantly though, cannabis in the early 1990s contained, on average, half to a third as much THC as it does now and always a healthy buffer of CBD.  The addictiveness of so-called ‘skunk’ with zero or very little CBD, is several times greater than the cannabis available 20 to 30 years ago.

It’s important to add that Rupert was also very badly failed by the dire state of mental health services. Surrey and Borders Partnership NHS Foundation Trust, a specialist provider of mental health and drug treatment services said that he needed to be admitted but a bed was not available.  It was just a few days later that he committed suicide.

Nicholas Monson has called for so-called ‘skunk’ to be made a class A drug but also for lower potency cannabis, with a maximum THC:CBD ratio of 3:1 to be made legally available through a regulated system.  Theresa May wrote to him after reading coverage of the story in the press.  She expressed her sympathy and said how she shared his concerns.  Importantly, she suggested that Lord Monson prepare a paper and a presentation to the Home Office on his proposals.  This is a tremendous opportunity towards introducing measures that will better protect vulnerable people like Rupert and also for wider reform of the cannabis laws that will reduce all the harms presently caused by prohibition.  Cannabis would be purchased from government licensed outlets just like alcohol and the aim would be to collapse the criminal market just like the market in dangerous, ‘moonshine’ whisky.

CLEAR does not agree that raising so-called ‘skunk’ to class A would be an effective measure.  It would be virtually impossible to enforce, requiring a massive increase in laboratory testing of cannabis and the supply of high potency varieties would simply be pushed underground. The price will go up and all the harms of a criminal market will be increased.  All the evidence is that drug classification or penalties have absolutely no effect whatsoever on consumption.  However, Lord Monson suggests that all personal cannabis possession should be decriminalised and police would focus only on dealers in so-called ‘skunk’.  There is a very strong argument that with high quality cannabis available legally, people would turn away from the black market.

Of course, we support the idea of legally available cannabis with a maximum THC:CBD ratio of 3:1.  This could be the basis of a system that could work very successfully. The product would be available only through a limited number of licensed outlets to adults only.  It would be supplied in appropriate packaging with detailed labelling of contents.  Possession of any cannabis not in this packaging would be reasonable grounds for it to be seized and tested.

Lord Nicholas Monson, Peter Reynolds

This will, of course, provoke outrage amongst many cannabis consumers, particularly those who grow their own but it would be fantastic progress.  It would usher in a far more rational, sensible regime where we could establish real data about harms and risks.  If appropriate, this could lead to the regulation of higher potency varieties.  Of course, we recognise that for medical use, a completely different approach to cannabinoid content is required and much higher potency may be necessary in some instances.

CLEAR is in the business of reform and this is the most likely path to reform that has ever emerged in the UK.  We are not in the business of promoting a cannabis market which enthusiasts and connoisseurs would regard as some sort of utopia.  The only purpose of any drugs policy must be to reduce harm and this proposal, if implemented, would massively reduce all the social harms caused by prohibition and reduce the risk of health harms.

Finally, it has to be said that, in typical fashion, a substantial part of the cannabis community has reacted in almost hysterical anger to Lord Monson’s proposals.  The only effect of such behaviour is to hold back reform.  We have been horrified and disgusted at the abuse directed at the Monson family.  It has shown cannabis consumers in the very worst light and demonstrated that some are so stupid that they damage the very cause they seek to advocate.  Nicholas Monson is a grieving father who, despite his agony, has seen the rational way forward and lent his energy and commitment towards reform that will benefit everyone.  We stand alongside him and we urge all cannabis consumers to consider these ideas carefully – and please, lend us your support!

Lord Nicholas Monson adds:

“The motivation for my campaign is to protect the young and vulnerable in particular from ingesting any substance whose contents can have a deleterious short or long term effect on their minds. To watch one’s son spiral into psychosis from a heavy usage of skunk is distressing to behold. Rupert’s psychiatric team put his psychosis down to skunk. This is unequivocal. Yes there are other psychoactive drugs around but skunk is what did for Rupert. It so happens that the remedy for skunk is a legalised and regulated market in cannabis where clear information is available. This should be applauded by the recreational cannabis community. Separately I have long supported the medical community’s initiatives to prescribe variants of cannabis with high CBD for people suffering from a wide variety of conditions.”

Written by Peter Reynolds

June 7, 2017 at 7:10 pm

A Significant Day For Cannabis Law Reform In The UK.

with 2 comments

This Thursday past, 25th May 2017, was the inaugural general meeting of the Cannabis Trades Association UK (CTAUK).

While this may not excite your average cannabis consumer too much, it represents a very important, even momentous occasion in our progress towards a regulated cannabis market.  Anyone spotting our meeting room would have seen it as just another group of business people in a day long meeting with Powerpoint presentations, flipcharts and gallons of coffee and mineral water.  GSK were just down the corridor, an insurance company was next door, it all looked very corporate and pretty boring.

This is exactly the point.  We are bringing cannabis into the mainstream, overcoming the stigma, making it respectable.  The idea that the Holiday Inn at Gatwick would have signs pointing to a ‘cannabis’ meeting would have been unthinkable until very recently.

Of course, CTAUK is concerned only with the legal cannabis trade so, in the main, that means CBD products but membership has started to expand rapidly.  In the coming weeks we anticipate we will be joined by UK hemp growers and a very important new medical cannabis research consortium.  Within the next few months we expect almost every significant player in all aspects of the UK cannabis market to be part of the association.

So, although at first glance, this boring business meeting may not excite CLEAR members and followers, it heralds the dawn of a new age.  Cannabis is coming out of the shadows. Reform is just round the corner.

Twenty years ago similar meetings took place in California, fifteen years ago similar meetings were held in Canada, Israel, the Netherlands and other US states.  Just three or four years ago they were happening in Colorado, Washington, Oregon, etc.  The UK’s time has come. Not a joint was rolled, not a bong was lit, there wasn’t a vapouriser or a hash cookie to be seen.  No longer are we playing at this, it’s now become serious.

Written by Peter Reynolds

May 27, 2017 at 4:20 pm

Lord Monson and CLEAR to Campaign for a Regulated Cannabis Market.

leave a comment »

Lord Nicholas Monson, Peter Reynolds

Lord Nicholas Monson, whose son Rupert committed suicide after he had become psychotic from ‘skunk’, has teamed up with CLEAR Cannabis Law Reform to campaign for a safer, regulated cannabis market.

‘Skunk’ is a form of cannabis with zero or very little CBD that can be harmful to young people and the vulnerable. The criminal market has driven the production of ‘skunk’ with high levels of THC, the psychoactive compound and low levels of CBD, the protective, anti-psychotic compound. The absence of regulation and control has also led to sales of highly dangerous products such as ‘Spice’ which contain an extremely potent, synthetic form of THC without any balancing CBD.

Lord Monson says:

“It is urgent that the government takes the historic step of legalising and regulating more traditional forms of cannabis and puts severe penalties in place for those dealing in skunk.”  

CLEAR Cannabis Law Reform is the UK’s largest and longest established drugs policy reform group.  It campaigns for medicinal cannabis on prescription by doctors and a regulated market for adults.

Peter Reynolds, president of CLEAR, says:

“We are honoured to work alongside Lord Monson towards a safer cannabis market that will reduce harm instead of the present policy that maximises all harms.  Just like the policy that President Trudeau is introducing in Canada and already exists across much of the USA, we must rigorously restrict access by children and those with developing brains and ensure that safe, properly regulated cannabis with a good proportion of CBD is available for adults.”

Written by Peter Reynolds

May 18, 2017 at 2:18 pm